Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073346 · ClinicalTrials.gov registry record · Phase 1
Pilot Trial of Cognitive and Behavioral Treatment of Compulsive Hoarding Compared to Wait List Control
A Phase 1 study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT00073346: Completed Phase 1 study, sponsored by Boston University Charles River Campus.
NCT00073346 is a Phase 1 study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 52 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00073346, a Phase 1 study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study developed and tested a specialized cognitive and behavioral treatment for the symptoms of hoarding disorder, including excessive acquiring, difficulty discarding items, and extensive clutter in the home.
Primary Outcome
Self-report questionnaire of hoarding severity; total score range = 0 to 92; higher values indicate more symptoms
Interventions
- BEHAVIORAL Cognitive Behavioral Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2003-09-01 |
| Est. Completion | 2008-07-09 |
| Phase | Phase 1 |
What the finished NCT00073346 record still lists
NCT00073346 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Treatment is the first listed.
NCT00073346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00073346 about?
NCT00073346 is a clinical study titled "Pilot Trial of Cognitive and Behavioral Treatment of Compulsive Hoarding Compared to Wait List Control". This study developed and tested a specialized cognitive and behavioral treatment for the symptoms of hoarding disorder, including excessive acquiring, difficulty discarding items, and extensive clutter in the home.
What is the current status of trial NCT00073346?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2003-09-01. Estimated completion is 2008-07-09.
What interventions are being tested in trial NCT00073346?
The interventions under investigation include: Cognitive Behavioral Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00073346?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00073346's enrollment target sits among peer trials
52 956th of 2000 higher than 1,032 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI